Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Macular Edema in BRVO with Fair Visual Acuity
NCT01795209Phase 4Terminated
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2017
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in macular edema, branch retinal vein occlusion (BRVO), sponsored by Seoul National University Bundang Hospital. Started Jan 2013; status: terminated.
02
Drugs
ranibizumab
03
Conditions
macular edemabranch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on NCT01795209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795209.